DanCann Pharma A/S publishes Q2-2023 report
COPENHAGEN, Denmark, 31 August 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the second quarter of 2023. The Q2-2023 report is available as an attached document to this press release and at www.dancann.com.SUMMARY: GROUP KEY FIGURES Q2-2023: 01/01/23 - 30/06/23 01/01/22 - 30/06/22 01/04/23 - 30/06/23 01/04/22 - 30/06/22 01/01/22 - 31/12/22Net sales